Development and Initial Validation of a Brief Self-Report Measure of Cognitive Dysfunction in Fibromyalgia - 31/05/15
, Stephen G. Schilling †, Jenna Goesling ‡, David A. Williams ‡, §Abstract |
Pain is often the focus of research and clinical care in fibromyalgia (FM); however, cognitive dysfunction is also a common, distressing, and disabling symptom in FM. Current efforts to address this problem are limited by the lack of a comprehensive, valid measure of subjective cognitive dysfunction in FM that is easily interpretable, accessible, and brief. The purpose of this study was to leverage cognitive functioning item banks that were developed as part of the Patient Reported Outcomes Measurement Information System (PROMIS) to devise a 10-item short form measure of cognitive functioning for use in FM. In study 1, a nationwide (U.S.) sample of 1,035 adults with FM (age range = 18–82, 95.2% female) completed 2 cognitive item pools. Factor analyses and item response theory analyses were used to identify dimensionality and optimally performing items. A recommended 10-item measure, called the Multidimensional Inventory of Subjective Cognitive Impairment (MISCI) was created. In study 2, 232 adults with FM completed the MISCI and a legacy measure of cognitive functioning that is used in FM clinical trials, the Multiple Ability Self-Report Questionnaire (MASQ). The MISCI showed excellent internal reliability, low ceiling/floor effects, and good convergent validity with the MASQ (r = −.82).
Perspective |
This paper presents the MISCI, a 10-item measure of cognitive dysfunction in FM, developed through classical test theory and item response theory. This brief but comprehensive measure shows evidence of excellent construct validity through large correlations with a lengthy legacy measure of cognitive functioning.
Le texte complet de cet article est disponible en PDF.Highlights |
• | A brief measure of perceived cognitive function in fibromyalgia was developed. |
• | It is the Multidimensional Inventory of Subjective Cognitive Impairment (MISCI). |
• | The 10-item MISCI demonstrated excellent internal consistency reliability. |
• | The MISCI is normally distributed and has low rates of ceiling and floor effects. |
• | The MISCI showed good construct validity in correlations with legacy measures. |
Key words : Fibromyalgia, cognitive functioning, self-report, Patient Reported Outcomes Measurement Information System (PROMIS), Multidimensional Inventory of Subjective Cognitive Impairment (MISCI)
Plan
| Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases under award number U01AR55069-01 (principal investigator: D.A.W.) and award number 1K01AR064275 (principal investigator: A.L.K.). These data were presented in abbreviated format as a scientific poster at the 34th Annual Meeting of the American Pain Society, May 13-16, 2015, in Palm Springs, CA. |
|
| The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
| The authors have no conflicts of interest to report. |
Vol 16 - N° 6
P. 527-536 - juin 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
